Across TCGA pan-cancer cohorts, GPR160P1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of GPR160P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where GPR160P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GPR160P1 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

KIRC, BRCA, and ESCA are the cancer types where GPR160P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GPR160P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.028	<.001	8	view →
BRCA	All	III,IV	−0.161	<.001	6	view →
ESCA	All	II,III,IV	+0.115	.016	2	view →
THCA	All	All	+0.020	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: GPR160P1 RNA expression & survival · all GPR160P1 data types